Cargando…

Benign histiocyte-rich pseudotumor in post treatment mediastinal Hodgkin's lymphoma

Benign xanthomatous pseudotumors are rare, mass forming lesions composed of lipid laden histiocytes and tumor necrosis following chemotherapy. We present a rare case of young 36 year old male with primary mediastinal Hodgkin's lymphoma who developed xanthomatous pseudotumor mimicking relapse at...

Descripción completa

Detalles Bibliográficos
Autores principales: Nilak, Yash Dilip, Nilak, Anjumara, Shafeek, Salim, Rudzki, Dr. Zbigniew, Chapman, Joanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911874/
https://www.ncbi.nlm.nih.gov/pubmed/31871516
http://dx.doi.org/10.1016/j.radcr.2019.10.018
_version_ 1783479337865969664
author Nilak, Yash Dilip
Nilak, Anjumara
Shafeek, Salim
Rudzki, Dr. Zbigniew
Chapman, Joanne
author_facet Nilak, Yash Dilip
Nilak, Anjumara
Shafeek, Salim
Rudzki, Dr. Zbigniew
Chapman, Joanne
author_sort Nilak, Yash Dilip
collection PubMed
description Benign xanthomatous pseudotumors are rare, mass forming lesions composed of lipid laden histiocytes and tumor necrosis following chemotherapy. We present a rare case of young 36 year old male with primary mediastinal Hodgkin's lymphoma who developed xanthomatous pseudotumor mimicking relapse at the site of original disease on positron emission tomography. This scenario places emphasis on histologic confirmation of suspected treatment failure or relapse.
format Online
Article
Text
id pubmed-6911874
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69118742019-12-23 Benign histiocyte-rich pseudotumor in post treatment mediastinal Hodgkin's lymphoma Nilak, Yash Dilip Nilak, Anjumara Shafeek, Salim Rudzki, Dr. Zbigniew Chapman, Joanne Radiol Case Rep Oncology Benign xanthomatous pseudotumors are rare, mass forming lesions composed of lipid laden histiocytes and tumor necrosis following chemotherapy. We present a rare case of young 36 year old male with primary mediastinal Hodgkin's lymphoma who developed xanthomatous pseudotumor mimicking relapse at the site of original disease on positron emission tomography. This scenario places emphasis on histologic confirmation of suspected treatment failure or relapse. Elsevier 2019-11-28 /pmc/articles/PMC6911874/ /pubmed/31871516 http://dx.doi.org/10.1016/j.radcr.2019.10.018 Text en Crown Copyright © 2019 Published by Elsevier Inc. on behalf of University of Washington. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Oncology
Nilak, Yash Dilip
Nilak, Anjumara
Shafeek, Salim
Rudzki, Dr. Zbigniew
Chapman, Joanne
Benign histiocyte-rich pseudotumor in post treatment mediastinal Hodgkin's lymphoma
title Benign histiocyte-rich pseudotumor in post treatment mediastinal Hodgkin's lymphoma
title_full Benign histiocyte-rich pseudotumor in post treatment mediastinal Hodgkin's lymphoma
title_fullStr Benign histiocyte-rich pseudotumor in post treatment mediastinal Hodgkin's lymphoma
title_full_unstemmed Benign histiocyte-rich pseudotumor in post treatment mediastinal Hodgkin's lymphoma
title_short Benign histiocyte-rich pseudotumor in post treatment mediastinal Hodgkin's lymphoma
title_sort benign histiocyte-rich pseudotumor in post treatment mediastinal hodgkin's lymphoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911874/
https://www.ncbi.nlm.nih.gov/pubmed/31871516
http://dx.doi.org/10.1016/j.radcr.2019.10.018
work_keys_str_mv AT nilakyashdilip benignhistiocyterichpseudotumorinposttreatmentmediastinalhodgkinslymphoma
AT nilakanjumara benignhistiocyterichpseudotumorinposttreatmentmediastinalhodgkinslymphoma
AT shafeeksalim benignhistiocyterichpseudotumorinposttreatmentmediastinalhodgkinslymphoma
AT rudzkidrzbigniew benignhistiocyterichpseudotumorinposttreatmentmediastinalhodgkinslymphoma
AT chapmanjoanne benignhistiocyterichpseudotumorinposttreatmentmediastinalhodgkinslymphoma